Skip to content

An evaluation of the change of plasma DHA concentration after the ingestion of DHA containing food.

An evaluation of the change of plasma DHA concentration after the ingestion of DHA containing food. - An evaluation of the change of plasma DHA concentration after the ingestion of DHA containing food.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000035763
Enrollment
10
Registered
2019-02-04
Start date
2019-02-03
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy adult

Interventions

Subjects receive a single dose of the active food. After the washout period (more than 6 days), subjects receive a single dose of the placebo food. Subjects receive a single dose of the placebo food.

Sponsors

Meiji CO.,Ltd.
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: 1) Subjects giving written informed consent 2)Males aged 20 to 35 years old when consent acquisition 3)Subjects whose body mass index (BMI) is from 18.5 kg/m2 to 25.0 kg/m2

Exclusion criteria

Exclusion criteria: 1)Subjects who routinely use pharmaceuticals, quasi-drugs and dietary supplement, and consume food for specified health uses more than two days per week 2) Subjects who have chronic diseases necessitating treatments and/or medications 3) Subjects who have significant abnormal blood pressure or blood test score 4) Subjects who have food allergy 5) Subjects who have lactose intolerance 6)Subjects who have digestive diseases or who received digestive surgical procedures 7) Subjects who are habitual smokers within a month of study enrollment 8) Subjects who donate 200 mL of blood within a month, or 400 mL of blood within three month 9) Subjects who participate in other clinical trials within the past month or have plans to participate in other clinical trials during this study period 10)Subjects who determine ineligible by the principal investigator or sub-investigator

Design outcomes

Primary

MeasureTime frame
Plasma DHA concentration

Secondary

MeasureTime frame
Plasma EPA concentration Plasma omega 3-fatty acids concentration(DHA and EPA) Plasma CCK concentration Plasma GLP-2 concentration

Countries

Japan

Contacts

Public ContactYusuke Omae

Meiji Co.,Ltd. Food Science & Technology Research Laboratories, R&D Division

yuusuke.ohmae@meiji.com042-632-5847

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026